Paysign (NASDAQ:PAYS) Shares Climb 3.8% – Should You Buy?

Paysign, Inc. (NASDAQ:PAYS) shares shot up 3.8% on Wednesday. The stock traded as high as $14.79 and last traded at $14.9010. Approximately 154,524 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 712,919 shares. The stock had previously closed at $14.36.

Wall Street Analyst Weigh In

PAYS has been the subject of a number of research reports. Barrington Research set a $15.00 price target on Paysign in a research note on Tuesday, August 11th. Weiss Ratings upgraded Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 29th. DA Davidson lifted their target price on Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, September 30th. Lake Street Capital boosted their price target on Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a report on Tuesday, September 15th. Finally, Wall Street Zen lowered Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Paysign currently has a consensus rating of “Buy” and a consensus price target of $15.00.

Paysign Stock Up 3.1%

The stock has a 50 day simple moving average of $12.63 and a 200 day simple moving average of $8.90. The company has a market capitalization of $836.17 million, a price-to-earnings ratio of 57.04 and a beta of 0.83.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.05. Paysign had a return on equity of 30.13% and a net margin of 15.67%.The business had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, analysts forecast that Paysign, Inc. will post 0.58 EPS for the current year.

Insider Activity

In other news, CEO Mark Newcomer sold 150,000 shares of Paysign stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $11.88, for a total transaction of $1,782,000.00. Following the sale, the chief executive officer owned 9,163,002 shares of the company’s stock, valued at approximately $108,856,463.76. The trade was a 1.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael C. Ngo sold 79,925 shares of the business’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total value of $1,018,244.50. Following the transaction, the insider owned 2,350,000 shares of the company’s stock, valued at approximately $29,939,000. This represents a 3.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 444,904 shares of company stock worth $5,328,124 in the last 90 days. 24.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc bought a new position in shares of Paysign in the second quarter worth $35,000. EFG International AG acquired a new stake in Paysign in the second quarter worth about $68,000. Caitong International Asset Management Co. Ltd grew its position in Paysign by 381.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company’s stock valued at $51,000 after buying an additional 7,825 shares in the last quarter. Quantbot Technologies LP bought a new position in Paysign in the 2nd quarter valued at about $97,000. Finally, The Manufacturers Life Insurance Company acquired a new position in Paysign during the 2nd quarter valued at about $100,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

Paysign Company Profile

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.